Literature DB >> 10516553

Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components.

I MacGregor1, J Hope, G Barnard, L Kirby, O Drummond, D Pepper, V Hornsey, R Barclay, H Bessos, M Turner, C Prowse.   

Abstract

BACKGROUND AND OBJECTIVES: To quantify the cellular isoform of prion protein (PrP(c)) in human blood using a new time-resolved dissociation-enhanced fluoroimmunoassay (DELFIA).
MATERIALS AND METHODS: The DELFIA was optimised for human blood samples and applied to isolated cell and plasma fractions from blood donations. The physicochemical properties of PrP(c) were analysed.
RESULTS: 26. 5% of blood PrP(c) was associated with the platelet fraction, 0.8% with polymorphonuclear leucocytes, 2.4% with mononuclear leucocytes, 1.8% with red cells and 68.5% with plasma (mean values from 4 processed donations).
CONCLUSION: The majority of blood PrP(c) is found in the platelet and plasma compartments.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516553     DOI: 10.1159/000031082

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  14 in total

1.  Scrapie infectivity in hamster blood is not associated with platelets.

Authors:  Karel Holada; Jaroslav G Vostal; Patrick W Theisen; Claudia MacAuley; Luisa Gregori; Robert G Rohwer
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Characterization of the prion protein in human urine.

Authors:  Ayuna Dagdanova; Serguei Ilchenko; Silvio Notari; Qiwei Yang; Mark E Obrenovich; Kristen Hatcher; Peter McAnulty; Lequn Huang; Wenquan Zou; Qingzhong Kong; Pierluigi Gambetti; Shu G Chen
Journal:  J Biol Chem       Date:  2010-07-29       Impact factor: 5.157

Review 3.  American fresh frozen plasma for neonates and children.

Authors:  D R Norfolk; A Glaser; S Kinsey
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

4.  Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development.

Authors:  Sonia M Vallabh; Chloe K Nobuhara; Franc Llorens; Inga Zerr; Piero Parchi; Sabina Capellari; Eric Kuhn; Jacob Klickstein; Jiri G Safar; Flavia C Nery; Kathryn J Swoboda; Michael D Geschwind; Henrik Zetterberg; Steven E Arnold; Eric Vallabh Minikel; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-01       Impact factor: 11.205

5.  Normal cellular prion protein is a ligand of selectins: binding requires Le(X) but is inhibited by sLe(X).

Authors:  Chaoyang Li; Poki Wong; Tao Pan; Fan Xiao; Shaoman Yin; Binggong Chang; Shin-Chung Kang; James Ironside; Man-Sun Sy
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

6.  Shedding light on prion disease.

Authors:  Markus Glatzel; Luise Linsenmeier; Frank Dohler; Susanne Krasemann; Berta Puig; Hermann C Altmeppen
Journal:  Prion       Date:  2015       Impact factor: 3.931

7.  Proteolytic processing of the prion protein in health and disease.

Authors:  Hermann C Altmeppen; Berta Puig; Frank Dohler; Dana K Thurm; Clemens Falker; Susanne Krasemann; Markus Glatzel
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

8.  B cells and platelets harbor prion infectivity in the blood of deer infected with chronic wasting disease.

Authors:  Candace K Mathiason; Jeanette Hayes-Klug; Sheila A Hays; Jenny Powers; David A Osborn; Sallie J Dahmes; Karl V Miller; Robert J Warren; Gary L Mason; Glenn C Telling; Alan J Young; Edward A Hoover
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

Review 9.  Variant Creutzfeldt-Jakob disease: a summary of current scientific knowledge in relation to public health.

Authors:  M B Coulthart; N R Cashman
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

10.  Detection of proteinase K resistant proteins in the urine of patients with Creutzfeldt-Jakob and other neurodegenerative diseases.

Authors:  Reza Dabaghian; Inga Zerr; Uta Heinemann; Gianluigi Zanusso
Journal:  Prion       Date:  2008 Oct-Dec       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.